Amphastar Pharmaceuticals, Inc.
AMPHStock
$19.86−14.33%52W
Market Cap$855.40M
P/E8.72x
Div yield—
Beta0.90
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-40.59%
Price vs S&P 500 (4W)-4.19%
VGM Score60.08
Market Capitalization$855.40M
P/E Ratio (Annual)8.72x
Earnings Surprise History
Q1 260.42est. 0.72
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.85
3.69
2.58
2.50
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AMPHAmphastar Pharmaceuticals, Inc. | A | C | C | $19.86 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Amphastar Pharmaceuticals manufactures generic and proprietary injectable, inhalation, intranasal, and insulin products for hospitals and urgent care settings. Its products are distributed through group purchasing organizations and drug wholesalers, with operations primarily in the United States and supplemented by facilities in China and France.